Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Patients With Nasopharyngeal Carcinoma Treated With Concurrent Chemoradiotherapy

키워드

참고문헌 (30)

1. Al-Sarraf M, "Nasopharyngeal carcinoma", Curr Treat Options Oncol, 3(1), pp.21~32 (2002)
2. 김연실, "Radiation Therapy Combined with (or without) Cisplatin-based Chemotherapy for Patients with Nasopharyngeal Cancer: 15-years Experience of a Single Institution in Korea", Cancer Research and Treatment, 40(4), pp.155~163 (2008), 대한암학회
3. Zhang L, "The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population:a meta-analysis of the phase III randomized trials", BMC Cancer, 10, pp.558~ (2010)
4. Lu H, "Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia", Cancer Treat Rev, 35(4), pp.345~353 (2009)
5. Liu MT, "Prognostic factors affecting the outcome of nasopharyngeal carcinoma", Jpn J Clin Oncol, 33(10), pp.501~508 (2003)
6. Farias TP, "Prognostic factors and outcome for nasopharyngeal carcinoma", Arch Otolaryngol Head Neck Surg, 129(7), pp.794~799 (2003)
7. Lee AW, "Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence", Int J Radiat Oncol Biol Phys, 26(5), pp.773~782 (1993)
8. Sham JS, "Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival", Head Neck, 13(4), pp.298~310 (1991)
9. Liu WS, "The role of pretreatment FDG-PET in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy", Int J Radiat Oncol Biol Phys, 82(2), pp.561~566 (2012)
10. Chan SC, "Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value", Oral Oncol, 45(1), pp.52~58 (2009)
11. Fletcher JW, "Recommendations on the use of 18F-FDG PET in oncology", J Nucl Med, 49(3), pp.480~508 (2008)
12. Schwartz DL, "FDG-PET prediction of head and neck squamous cell cancer outcomes", Arch Otolaryngol Head Neck Surg, 130(12), pp.1361~1367 (2004)
13. Higgins KA, "Turkington TG, et al. Analysis of pretreatment FDG-PET SUV parameters in headand-neck cancer: tumor SUVmean has superior prognostic value", Int J Radiat Oncol Biol Phys, 82(2), pp.548~553 (2012)
14. fluoro-2-deoxy-D-glucose, "Int J Radiat Oncol Biol Phys", 2004, 1295~1300
15. Lee P, "Metabolic tumor burden predicts for disease progression and death in lung cancer", Int J Radiat Oncol Biol Phys, 69(2), pp.328~333 (2007)
16. 최규호, "Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET", CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery, 2011, pp.45(1), 43~51[DOI]
17. Hyun SH, "Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma", Ann Surg Oncol, 17(1), pp.115~122 (2010)
18. Moon SH, "Prognostic value of 18F-FDG PET", CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters, 2013, pp.35(1), 15~22
19. Bum Soo Kim, "The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET", CT, 2011, pp.45(1), 36~42[DOI]
20. Lee HY, "Volumebased parameter of 18)F-FDG PET", CT in malignant pleural mesothelioma:prediction of therapeutic response and prognostic implications, 2010, pp.17(10), 2787~2794
21. La TH, "Metabolic tumor volume predicts for recurrence and death in head-andneck cancer", Int J Radiat Oncol Biol Phys, 74(5), pp.1335~1341 (2009)
22. Chan SC, "Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification", Nucl Med Commun, 32(11), pp.989~996 (2011)
23. Juweid ME, "Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma", J Clin Oncol, 25(5), pp.571~578 (2007)
24. Zheng Y, "Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers", Biometrics, 62(1), pp.279~287 (2006)
25. fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer, "J Clin Oncol", 2005, 1136~1143
26. Soret M, "Partial-volume effect in PET tumor imaging", J Nucl Med, 48(6), pp.932~945 (2007)
27. Chu ST, "Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate", Eur Arch Otorhinolaryngol, 265(Suppl 1:), pp.S115~S120 (2008)
28. Takes RP, "Future of the TNM classification and staging system in head and neck cancer", Head Neck, 32(12), pp.1693~1711 (2010)
29. 문승환, "Prognostic Significance of Volume-Based PET Parameters in Cancer Patients", Korean Journal of Radiology, 14(1), pp.1~12 (2013), 대한영상의학회[DOI]
30. 이수진, "Prognostic Value of Volume-Based 18F-Fluorodeoxyglucose PET", CT Parameters in Patients with Clinically Node-Negative Oral Tongue Squamous Cell Carcinoma, 2012, pp.13(6), 752~759[DOI]

관련 논문AI추천